Sign Up
Stories
Oncology Drugs Market Soars by 2030
Share
ADC Therapeutics Reports Financial Progr...
Advancements in Lymphoma Treatments
Basal Cell Carcinoma Treatment Market Ex...
Oncology Drugs Market Surge 2030
Oncology Drugs Market Surges Ahead
Overview
API
The global oncology drugs market is set to reach $474.06 billion by 2030, driven by a CAGR of 11.53% due to increasing cancer cases and R&D investments. Targeted therapy and injectables lead the market, with North America at the forefront. Major players include AbbVie, Roche, and Pfizer.
Ask a question
How could the consolidation of pharmaceutical companies through mergers and acquisitions influence competition and innovation in the oncology drugs sector?
How might the increasing prevalence of cancer globally impact the growth of the oncology drugs market?
What specific advancements in treatment types are contributing significantly to the market's expansion?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2029
Nov 2029
Dec 2029
Coverage
strat